{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"After drug infusion, participants will be closely monitored for at least 4 hours for side effects","groups":[{"description":"Denileukin Diftitox (Ontak) administered Post Autologous Transplantation.\n\nDenileukin Diftitox (Ontak) : After receiving their stem cell transplant on Day 0, participants will receive study agent via a 30 minute infusion. Participants will also receive a 30 minute infusion of study agent on Day 21.\n\nFollow-up visits for clinical assessment, blood draws for routine clinical laboratory studies and for immuno-correlative studies will also take place on days 42, 90, 180 and 360.","id":"OG000","title":"Denileukin Diftitox (Ontak)"}],"reportingStatus":"POSTED","timeFrame":"Up to 21 days post transplant","title":"Assess Toxicities of Giving Two Doses of Ontak at Days 0 and 21 Post Autologous Stem Cell Transplantation in a Dose Escalation Fashion.","type":"PRIMARY"}